Wolff Parkinson White Syndrome An Uncommon Cause Of Palpitations
Category : Health » Parkinson Disease
a rapid ventricular response due to underlying Wolff- Parkinson-White (WPW) syndrome. . WOLFF-PARKINSON-WHITE SYNDROME. The normal conduction system of .
Download File
Free PDF eBooks Download
Health
Parkinson Disease
Content Summary :
However, clinicians must be aware of and alert for more serious underly-ing conditions. In this article, we report the case of a young man who presented with palpitations and a wide complex tachycardia on electrocardiogram (ECG). The patient’s symptoms were caused by atrial fibrillation with a rapid ventricular response due to underlying Wolff-Parkinson-White (WPW) syndrome. WPW syndrome, which is classified among the par- oxysmal supraventricular tachycardias (PSVTs), is a relatively uncommon cardiac conduction disorder that occasionally may cause early excitation (preexcitation) of the ventricles due to antegrade atrioventricular (AV) conduction through an accessory pathway. Patients with WPW syndrome may present with preexcited atrial fibrillation. ECG tracings of patients who have WPW syndrome typically reveal a narrow QRS com-plex, but WPW syndrome associated with preexcited atrial fibrillation may produce a wide QRS complex on ECG. These ECG findings are commonly confused with other causes of wide QRS complex tachycardia, such as ventricular tachycardia.
Favorite Parkinson Disease PDF File
Department of Neurology Department of Neurology. Parkinson Center of Oregon . No part of this book may be reproduced or transmitted in any form or by any .
Adult Stem Cells Treat Parkinson 39 s in Humans and Animals . This treatment provided. an average 61 improvement in motor function. .
primary treatment for symptomatic Parkinson 39 s disease . are effective treatments for these patients. 30. Nonpharmacologic Treatment .
set Parkinson 39 s starting before age 21 years fre . Parkinson 39 s Disease. Treatment Complications. Exercise and Nutrition. The Workplace .
new treatment opportunities. and therapies available to. people with Parkinson 39 s disease. . in Parkinson 39 s. Treatment. SPRING CONFERENCE Approved for 2 .